EOLS- Evolus, Inc.

Name: Evolus, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Evolus, Inc. (EOLS) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. EOLS is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Moatazedi David	604.7K	$3.92M	-
Other	Avelar Rui	427.4K	$2.77M	-
Dir	Malik Vikram	321.1K	$2.08M	-
CFO	Mitchell Tatjana	226.1K	$1.46M	-
CFO	Beaver Sandra	167.1K	$1.08M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 20, 2026	Moatazedi David66	See Remarks	Sell	13,669	$4.75	$64,929.12	-2.2%	-	-
Mar 20, 2026	Avelar Rui66	See Remarks	Sell	3,119	$4.75	$14,815.25	-0.7%	-	-
Dec 22, 2025	Moatazedi David66	See Remarks	Sell	10,539	$7.15	$75,361.23	-2.9%	-34.9%	-
Dec 22, 2025	Avelar Rui66	See Remarks	Sell	2,261	$7.15	$16,167.73	-0.6%	-34.9%	-
Aug 22, 2025	Yamagishi-Dressler Tomoko74	Chief Marketing Officer	Sell	5,722	$7.51	$42,972.22	-6.0%	-13.8%	-
Aug 15, 2025	Stewart Brady	Director	Buy	30,000	$6.82	$204,486.00	+51.2%	+9.5%	-
Jun 16, 2025	Moatazedi David66	See Remarks	Sell	127,905	$10.03	$1,283,195.27	-14.6%	-33.4%	-
Jun 9, 2025	White Albert G III65	Director	Buy	20,000	$9.45	$189,000.00	+65.8%	-21.1%	-
May 13, 2025	Beaver Sandra66	Chief Financial Officer	Sell	6,494	$10.02	$65,069.88	-3.7%	-43.0%	-
May 12, 2025	Avelar Rui66	See Remarks	Sell	3,385	$9.87	$33,396.75	-0.9%	-42.2%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC